4.7 Article

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1

期刊

JOURNAL OF TRANSLATIONAL MEDICINE
卷 20, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12967-021-03206-5

关键词

Triple-negative breast cancer; CTPS1; Progression; YBX1; Transcriptional activation

资金

  1. Joint funds for the Innovation of Science and Technology, Fujian Province [2018Y9205, 2019Y9054, 2019Y9103]
  2. Natural Science Foundation of Fujian Province [2020J01995]
  3. Fujian Young Teacher Education Research Project [JAT170228]
  4. Fujian Provincial Health Technology Project [2020QNA039]

向作者/读者索取更多资源

CTPS1 is upregulated in TNBC and is associated with poor prognosis in patients. Silencing CTPS1 inhibits TNBC cell proliferation, migration, and invasion. YBX1 can bind to the promoter of CTPS1 and promote its transcription. Furthermore, YBX1 expression is positively correlated with CTPS1 in TNBC tissues.
Background Cytidine nucleotide triphosphate synthase 1 (CTPS1) is a CTP synthase which play critical roles in DNA synthesis. However, its biological regulation and mechanism in triple-negative breast cancer (TNBC) has not been reported yet. Methods The expression of CTPS1 in TNBC tissues was determined by GEO, TCGA databases and immunohistochemistry (IHC). The effect of CTPS1 on TNBC cell proliferation, migration, invasion, apoptosis and tumorigenesis were explored in vivo and in vitro. In addition, the transcription factor Y-box binding protein 1 (YBX1) was identified by bioinformatics methods, dual luciferase reporter and chromatin immunoprecipitation (CHIP) assays. Pearson correlation analysis was utilized to assess the association between YBX1 and CTPS1 expression. Results CTPS1 expression was significantly upregulated in TNBC tissues and cell lines. Higher CTPS1 expression was correlated with a poorer disease-free survival (DFS) and overall survival (OS) in TNBC patients. Silencing of CTPS1 dramatically inhibited the proliferation, migration, invasion ability and induced apoptosis of MDA-MB-231 and HCC1937 cells. Xenograft tumor model also indicated that CTPS1 knockdown remarkably reduced tumor growth in mice. Mechanically, YBX1 could bind to the promoter of CTPS1 to promote its transcription. Furthermore, the expression of YBX1 was positively correlated with CTPS1 in TNBC tissues. Rescue experiments confirmed that the enhanced cell proliferation and invasion ability induced by YBX1 overexpression could be reversed by CTPS1 knockdown. Conclusion Our data demonstrate that YBX1/CTPS1 axis plays an important role in the progression of TNBC. CTPS1 might be a promising prognosis biomarker and potential therapeutic target for patients with triple-negative breast cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据